Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical ketorolac to reduce postoperative sequela after impacted lower wisdom tooth removal
TCTR20260301005Phase 1Active, not recruiting
- Sponsor
- tabarak abdullah waheed
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of ketorolac in postoperative pain, sponsored by tabarak abdullah waheed. Primary endpoint: Postoperative pain. Started Dec 2025; status: active, not recruiting.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on TCTR20260301005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260301005.